The full-year beat rests on lapping a $169M cost spike, while three regions destock and Q1 free cash flow is negative $915M.
Thesis: The H2 setup is a comparison effect, not demand. 17% second-half EBITDA growth is anchored to lapping the largest single-quarter cost increase in company history, while channel destocking runs through India into 2024, diamide partners cut inventory for the rest of the year, and North America's record 28% growth came from pre-built pull-forward that management itself guides to 'return to normal.' Q1 free cash flow is negative $915M and gross debt rose $900M to 3.0x. Price is real; volume and cash are not.
Verdict: SHORT — Conviction: MEDIUM
Catalyst: Q2 print: management guides revenue flat and EPS down 9%. Confirmation that North American purchase patterns normalize and H1 EBITDA lands at 1% growth would validate that the raise is back-loaded and fragile.
Key Risk: If LatAm normalizes faster than expected and the $800M+ new product revenue lands on schedule, the guided numbers still get hit. Pricing is holding, mix is improving, and input costs are locked for Q3. The bear case needs three things to go wrong at once.
The Tell: CFO Sandifer, unprompted: 'Q3 of last year was the biggest cost increase we've ever had in our history, $169 million of cost increase in one quarter... lapping that big headwind from Q3 of 22 is a big factor in driving our second half EBITDA growth.' He stated the raise is a comparison, not demand.
Friction Level: HIGH_FRICTION — One side calls this a beat-and-raise machine worth a full position; the other calls the raise mechanical and says avoid. The split is whether 17% H2 EBITDA growth is structural demand or a lapped cost comparison. Sandifer said it plainly: lapping the $169M Q3 2022 headwind 'is a big factor in driving our second half EBITDA growth.'
Report not found
The report data is no longer available. Please return to the archive.